Rapid Influenza Diagnostic Test Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Rapid Influenza Diagnostic Test (RIDT) is an immunoassay that can confirm the presence of influenza A and B viral nuclear protein antigens in respiratory samples and display the results in a qualitative manner (positive versus negative). In the United States, many RIDTs are commercially available.

Rapid Influenza Diagnostic Test (RIDT) market size is projected to reach US$ 2140.3 million by 2027, from US$ 1173.4 million in 2019, at a CAGR of 9% during 2021-2027.

Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Type

• Digital RIDTs
• Conventional RIDT

Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Application

• Hospitals
• POCT
• Others

The following players are covered in this report:

• BD
• Abbot (Alere)
• Quidel
• Roche
• Thermo Fisher Scientific
• Meridian Bioscience
• Analytik Jena

Scope of the Report

The research study analyzes the global Rapid Influenza Diagnostic Test industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Rapid Influenza Diagnostic Test Market Report

1. What was the Rapid Influenza Diagnostic Test Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of Rapid Influenza Diagnostic Test Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Rapid Influenza Diagnostic Test Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.